While Brexit has brought about a period of uncertainty in the UK’s pharmaceutical industry, what is an appropriate response by medical writers at such a time? Few successful businesses stand idle and wait for things to  happen. Taking a look at the current climate of outsourcing and the UK’s business environment in terms of investment, now may be the time for writers to consider their strengths and weaknesses, diversifying their portfolio, and being strategic in seeking a competitive advantage.